RPSAP20

Across TCGA pan-cancer cohorts, RPSAP20 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated RPSAP20 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RPSAP20 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPSAP20 expression acts as an unfavorable survival marker, although some lineages such as LUSC and CHOL show a favorable association.

ACC, BRCA, and PRAD are the cancer types where RPSAP20 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Quartile	III,IV	0.490	0.901	.014	26	view →
BRCA	OS	Median	IV	0.373	0.754	.012	18	view →
PRAD	DFS	Tertile	All	0.820	0.913	.001	18	view →
CESC	DFS	Quartile	III,IV	0.420	0.691	.033	16	view →
KIRP	DFS	Tertile	III,IV	0.476	0.795	.010	15	view →
LGG	DFS	Quartile	All	0.647	0.773	.001	13	view →
MESO	OS	Tertile	IV	0.296	0.673	.021	10	view →
LUSC	OS	Median	II,III,IV	0.793	0.546	.016	10	view →
COAD	DFS	Tertile	III,IV	0.535	0.689	.040	9	view →
KICH	DFS	Tertile	IV	0.269	0.784	.045	9	view →
CHOL	OS	Quartile	All	1.000	0.640	.007	8	view →
KIRC	DFS	Median	II,III,IV	0.451	0.590	.017	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

RPSAP20–ACC (OS)

Open the ACC breakdown →